Singaporean sovereign wealth fund Temasek led a USD109m Series D2 for Indian health and fitness startup CureFit, with participation from Chiratae Ventures and Accel Partners, with follow-on from Castle Investments, Unilever Swiss Holdings, Pathiti Investment Trust, and Epiq Capital. New investors GableHorn Investments and Ascent Capital also contributed to the round. Read more